CIP
IDYA icon

Chartwell Investment Partners’s IDEAYA Biosciences IDYA Stock Holding History

Chartwell Investment Partners’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$473K Buy
14,931
+116
+0.8% +$4.4K 0.02% 402
2024
Q2 		$521K Sell
14,815
-2,426
-14% -$96.1K 0.02% 392
2024
Q1 		$756K Buy
+17,241
New +$741K 0.03% 384

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Chartwell Investment Partners's IDYA Position: Q3 2024 in Review

Chartwell Investment Partners increased its IDEAYA Biosciences (IDYA) stake by 0.78% in Q3 2024, buying an estimated $4.4K and bringing the position to 14,931 shares worth $473K. The position accounts for 0.02% of the portfolio, ranked #402.

Chartwell Investment Partners first reported a position in IDYA in Q1 2024 and has held it in 3 quarters since. The position peaked at $756K in Q1 2024. 209 funds tracked by Wall St. Rank hold IDYA as of Q3 2024.

  • Chartwell Investment Partners held 14,931 shares of IDEAYA Biosciences worth $473K as of Q3 2024.
  • Chartwell Investment Partners bought 116 IDEAYA Biosciences shares in Q3 2024, an estimated $4.4K.
  • IDEAYA Biosciences made up 0.02% of Chartwell Investment Partners's portfolio in Q3 2024, its #402 holding.
  • Chartwell Investment Partners first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 3 quarters since.
  • Chartwell Investment Partners's IDEAYA Biosciences position peaked at $756K in Q1 2024.
  • 209 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.